Pyrimidine Azepine Targets the Plasmodium bc ₁ Complex and Displays Multistage Antimalarial Activity

Area of Science:

• Parasitology
• Medicinal Chemistry
• Drug Discovery

Background:

• Malaria control requires new chemotherapeutics targeting diverse parasite stages.
• High-throughput screening aids in identifying novel antimalarial compounds.

Purpose of the Study:

• To validate the antimalarial activity of PyAz90, a pyrimidine azepine chemotype.
• To investigate the molecular target and efficacy of PyAz90 against Plasmodium parasites.

Main Methods:

• In vitro screening of Plasmodium berghei sexual stages.
• Testing PyAz90 activity against asexual and sexual stages of P. falciparum and P. vivax.
• Generating resistant parasites and conducting mitochondrial activity assays to identify the molecular target.

Main Results:

• PyAz90 demonstrated potent inhibition of parasite transmission to mosquitoes at nanomolar concentrations.
• The compound effectively inhibited asexual parasite multiplication with a rapid action profile.
• Cytochrome b was identified as the molecular target of PyAz90.

Conclusions:

• PyAz90 is a promising antimalarial chemotype with activity against multiple parasite stages.
• The identified target, cytochrome b, is crucial for developing new antimalarials.
• Further exploration of PyAz90 could lead to novel therapies targeting the Plasmodium cytochrome bc1 complex.